Ethosuximide Plasma Concentrations
Authors:
- 1 January 1982
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 7 (2) , 176-180
Abstract
The relationship between oral dose and plasma concentration of ethosuximide was evaluated retrospectively in 198 epileptic patients aged 2.5 to 34 years. Age appears to be a major factor in determining the ethosuximide plasma level/dose (L/D) ratio. Children younger than 10 years had mean L/D ratios significantly lower (p<0.0003) than adolescents (10 to 15 years of age) and adults (16 to 34 years of age). Associated antiepileptic therapy reduced the ethosuximide L/D ratio; mean ethosuximide L/D ratios were significantly lower in patients also taking primidone (p < 0.0005) or valproic acid (p < 0.02). The correlation between the dose of ethosuximide administered and the plasma concentration was significant in the 3 age groups considered (p < 0.0004), but the wide scattering of individual plasma concentrations makes it impossible to predict what plasma concentration of ethosuximide will be obtained after a given dose. For this reason, routine monitoring of ethosuximide plasma concentrations still appears to be necessary, especially in children and patients on polytherapy.Keywords
This publication has 7 references indexed in Scilit:
- Factors Influencing Plasma Concentrations of EthosuximideClinical Pharmacokinetics, 1979
- Metabolism of ethosuximideClinical Pharmacology & Therapeutics, 1976
- Ethosuximide in the treatment of absence (petit mal) seizuresNeurology, 1975
- The absorption and excretion of ethosuximide.1973
- The determination of ethosuximide in serum by gas chromatography preliminary results of clinical applicationClinica Chimica Acta, 1971
- Ethosuximide Blood Levels in EpilepticsThe Journal of Clinical Pharmacology and The Journal of New Drugs, 1970
- Absorption and Elimination of Ethosuximide In ChildrenThe Journal of Clinical Pharmacology and The Journal of New Drugs, 1969